ACTRN12609000571279
Completed
Phase 3
Prospective non controlled study of immunogenicity of Human Papilloma Virus (HPV) Vaccine in groups at special risk of poor vaccine result
ational Health and Medical Research Council & Clinical Centre of Research Excellence(NHMRC CCRE) in Childhood and Adolescent Immunisation0 sites100 target enrollmentJuly 13, 2009
ConditionsSpecial Risk Groups1. Paediatric Rheumatalogical Disease2. Inflammatory Bowel Disease3. Acute Lymphoblastic Leukaemia4. Solid Organ Transplant Recipients (kidney and liver)5. Chronic Renal Disease6. Bone Marrow TranssplantThe response to the HPV vaccine will be studied within these 6 special risk groups.Special Risk Groups1. Paediatric Rheumatalogical Disease2. Inflammatory Bowel Disease3. Acute Lymphoblastic Leukaemia4. Solid Organ Transplant Recipients (kidney and liver)5. Chronic Renal Disease6. Bone Marrow TranssplantThe response to the HPV vaccine will be studied within these 6 special risk groups.Inflammatory and Immune System - Other inflammatory or immune system disorders
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Special Risk Groups1. Paediatric Rheumatalogical Disease2. Inflammatory Bowel Disease3. Acute Lymphoblastic Leukaemia4. Solid Organ Transplant Recipients (kidney and liver)5. Chronic Renal Disease6. Bone Marrow TranssplantThe response to the HPV vaccine will be studied within these 6 special risk groups.
- Sponsor
- ational Health and Medical Research Council & Clinical Centre of Research Excellence(NHMRC CCRE) in Childhood and Adolescent Immunisation
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Females aged 12\-26 years
- •Have been diagnosed by a specialist with one of the six chronic medical conditions described.
- •Special Risk Groups
- •1\. Paediatric Rheumatalogical Disease
- •2\. Inflammatory Bowel Disease
- •3\. Acute Lymphoblastic Leukaemia
- •4\. Solid Organ Transplant Recipients (kidney and liver)
- •5\. Chronic Renal Disease
- •6\. Bone Marrow Transsplant
Exclusion Criteria
- •Previous immunisation with HPV vaccine
- •Recognised contraindication to the receipt of the vaccine e.g. anaphylaxis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
A study to evaluate the immunogenicity and safety of smallpox vaccine as vaccination to monkeypox in healthy adultsJPRN-jRCTs031220171jiie Mugen50
Completed
Not Applicable
Brief intervention in substance use disorders: pilot studyIRCT201209301958N3Office of Psychosocial Health and Addiction, Ministry of Health30
Not yet recruiting
Phase 1
Probiotics to initiate ovulation in women with PolyCystic Ovarian Syndrome (PCOS) and Irritable Bowel Syndrome (IBS)ACTRN12612001192875niversity of South Australia16
Recruiting
Not Applicable
A prospective, controlled, clinical study to evaluate the impact of UV-irradiation on the electrical impedance spectroscopy scores of neviQ82.5Congenital non-neoplastic naevusDRKS00012456niversitätsklinikum Heidelberg50
Completed
Not Applicable
Prospective, non-interventional, open-label study on the prophylactic use of a pegylated filgrastim (Pelgraz®) to reduce the duration of neutropenia and the incidence of febrile neutropenia under conventional chemotherapy for the treatment of haematological malignancies and solid tumorsfebrile neutropeniaD70.0DRKS00017218ACCORD Healthcare GmbH1,665